loading

Processa Pharmaceuticals Inc Azioni (PCSA) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Operating Income/Loss
11.69%
-3.4888
-3.9508 -2.847 -2.7347 -3.4249
Income/Loss From Continuing Operations Before Tax
12.64%
-3.4366
-3.9339 -2.8344 -2.7287 -3.3847
Income/Loss From Continuing Operations After Tax
12.64%
-3.4366
-3.9339 -2.8344 -2.7287 -3.3847
Net Income/Loss
12.64%
-3.4366
-3.9339 -2.8344 -2.7287 -3.3847
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
205.25%
47.53
15.57 9.5268 0.15 3.276
Diluted Average Shares
205.25%
47.53
15.57 9.5268 0.15 3.276
Basic Earnings Per Share
72.00%
-0.07
-0.25 -0.30 -0.74 -1.03
Diluted Earnings Per Share
72.00%
-0.07
-0.25 -0.30 -0.74 -1.03
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):